Trouble viewing this email? Read it on the Web here.
Golden Helix Newsletter
 
Top biotech solution providers of 2017
Top biotech solution providers of 2017
by Andreas Scherer
President & CEO


It is a great honor for us to be recognized as one of the “Top 25 Biotechnology Solution Providers of 2017” by CIO Applications. You can find my interview with the editor here. We are incredibly thankful for the hundreds of organizations and thousands of users globally trusting our brand! Thank you for your support... Continue Reading

The Clinical Utility of the 1000 Genomes Variant Frequencies
The Clinical Utility of the 1000 Genomes Variant Frequencies
by Gabe Rudy
VP of Product & Engineering


We have a lot to thank the 1000 Genomes project for in the genomics community. By the collaborate efforts of many researchers and organizations, the project produced not only the first catalog of rare human variation but in the process standardized many things we take for granted, such as the VCF and BAM file formats... Continue Reading »

2017-18 Abstract Competition Has Begun!
2017-18 Abstract Competition Has Begun!
by Andreas Scherer
President & CEO


Golden Helix strives to enable precision medicine by developing powerful software that supports researchers with complex analysis. One of my favorite events of the year is our abstract competition that expands on our mission. This competition allows us to support our community by recognizing innovative ways to conduct genomic analysis. I am pleased to announce that our 2017-18 Abstract Competition has officially begun and encourage you all to participate! Continue Reading »

New and Updated Annotations
New and Updated Annotations
by Cody Sarrazin
Product Specialist


Golden Helix is excited to announce a new round of novel and updated annotations; including a frequency track, a region track, and a gene track. All three of these tracks were created with the use of VarSeq and its Convert Wizard functionality. First, the expansive 1000 genomes track (1kG) has been updated to include sub-population allele frequencies and heterozygous and homozygous sub-population counts. Also, Golden Helix now provides a region track with data taken from the Online Mendelian Inheritance in Man (OMIM) catalog to help support the recent CNV caller capability in both VarSeq and SVS suite product lines, as well as an updated Ensembl gene tracks for human genome GRCh 37 and GRCh 38 genome sequences... Continue Reading »
   CEO Corner
Andreas Scherer
We ended this year on a wonderful note. Golden Helix was selected as one of the top 25 solution providers for the biotech industry. This is a testament to the significant innovation we displayed over the last few years. Most importantly, it’s a testament to the wonderful feedback we receive from our clients. So, the entire Golden Helix team thanks you for your support. We are humbled by your trust in us, but we won’t stop here. We plan to continue to improve our products and launch new capabilities in 2018; more about this later. For now, I wish you a wonderful time with your friends and family over the holidays. And of course a terrific start into 2018.
 
  Recent Webcast

Genomic Prediction Methods in SVS

Watch our webcast recording

The Golden Helix SNP and Variation Suite (SVS) offers three methods for genomic prediction: Bayes C, Bayes C-pi and Genomic Best Linear Unbiased Predictors (GBLUP). This webcast will discuss the principles of genomic prediction. It describes how these methods are applied within SVS predicting phenotypes for both plant and animal species. In addition, we show how k-fold cross-validation can be utilized optimizing predictive models.
 
   Customer Success
We'd like to congratulate a number of our clients on their recent publications. To name a few: You can find our entire list of publications citing Golden Helix software here!
Facebook     Twitter     Linked In     Blog   YouTube


About Golden Helix
Golden Helix® is a global bioinformatics firm founded in 1998. Our largest outside investor is GlaxoSmithKline who invested early on into the company. We develop and sell an industry leading clinical solution that supports the analysis of sequencing data and the creation of clinical reports. Clinicians and researchers worldwide trust our solution. Over all these years we have accumulated a significant customer base conducting business with over 350 organizations globally with thousands of users leveraging our various analytics products. Our customers fall into five categories: Large Hospitals, Genetic Testing Labs, Pharmaceutical companies, major research organizations, and government organizations here in the US and internationally. Our work his referenced in over 1,100 publications such as Science, Nature and Nature Genetics.
 



Copyright 2000-2017 Golden Helix, Inc. All Rights Reserved.
To UNSUBSCRIBE from our mailing list, simply click here.
Golden Helix, Inc. | 203 Enterprise, Blvd. | Bozeman, MT | 59718
View our Privacy Policy.